IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026 - 20:22
IN8bio, a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, announced its financial results for the first quarter of 2026 along with key business updates. The company is advancing its next-generation gamma-delta T cell engager platform and expects to release initial animal data later this year.
In its glioblastoma program, IN8bio reported data showing a roughly 97 percent improvement in progression-free survival compared to standard-of-care treatment. The company plans to present updated median overall survival data at the ASCO 2026 conference.
IN8bio will host an R&D Day on May 21, 2026 in New York City to discuss its pipeline and future directions. The company continues to develop innovative gamma-delta T cell therapies designed to target and destroy cancer cells while potentially reducing side effects associated with traditional treatments.
Financial details from the first quarter were not disclosed in the summary, but the company remains focused on advancing its clinical programs and platform technology. IN8bio is headquartered in New York and trades on the Nasdaq under the ticker INAB.
MORE NEWS
June 22, 2026 - 04:41
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth NarrativeWest Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation...
June 21, 2026 - 02:37
Robinhood Is Becoming a Full-Service Financial Platform. Is the Stock a Buy?Robinhood has come a long way from its early days as a simple trading app for millennials. The company now offers retirement accounts, credit cards, and even crypto wallets. It is clearly trying to...
June 20, 2026 - 06:27
Does Intuitive Machines (LUNR) Equity Overhang Undercut Its Push Toward Recurring Lunar Infrastructure Revenue?Intuitive Machines is trying to build a business around recurring revenue from lunar infrastructure, but questions about its stock structure are giving investors pause. The company recently secured...
June 19, 2026 - 19:14
Regional Banks Stocks Q4 Teardown: CVB Financial (NASDAQ:CVBF) Vs The RestThe close of earnings season offers a useful moment to check in on how different companies are navigating the current economic climate. For investors tracking regional banks, the fourth-quarter...